Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEcofin U.s. $ Regulatory News (RNEW)

Share Price Information for Ecofin U.s. $ (RNEW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.525
Bid: 0.50
Ask: 0.55
Change: 0.00 (0.00%)
Spread: 0.05 (10.00%)
Open: 0.52
High: 0.525
Low: 0.52
Prev. Close: 0.525
RNEW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Strategic Review

8 Sep 2023 07:00

RNS Number : 7853L
Ecofin US Renewables Infrastr.Trust
08 September 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION EU 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, TO US PERSONS OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO WOULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER TO SELL OR ISSUE, OR ANY SOLICITATION OF ANY OFFER TO PURCHASE, SUBSCRIBE FOR OR OTHERWISE ACQUIRE, ANY INVESTMENTS IN ANY JURISDICTION.

 

8 September 2023

 

ECOFIN U.S. RENEWABLES INFRASTRUCTURE TRUST PLC

(the "Company" or "RNEW")

 

Strategic Review

 

The U.S. renewable energy sector continues to offer expanding opportunities for stable investment and growth. RNEW plays an important role in the drive for a more sustainable future in the U.S. as an owner and operator of renewable energy assets. At the same time, the Board is conscious of the challenges the Company faces as a UK investment trust, including size and liquidity.

 

The last annual report also noted that consistent with good governance, the Board was open to exploring all options for the future of the Company, and in connection with this, approaches were made to another listed closed ended investment company in the sector with a view to combining the Company and the other vehicle through a scheme of reconstruction under Section 110 of the Insolvency Act 1986 ("Section 110") and rollover, to create a larger company with greater liquidity. However, the Company's proposal was not successful. The Company subsequently received interest from a different listed closed ended investment company within the wider renewables sector regarding a Section 110 combination, however the Board did not consider the proposal to be in the best interests of shareholders for a number of reasons.

 

Given the wide discounts impacting RNEW and other alternatives investment trusts, and the unfavourable short-term prospects to raise new equity, the Board has decided to undertake a review of the Company's strategy in order to maximise value for shareholders. The review will centre on a sale of the Company's assets. If successful, and subject to the terms of such disposal, it is expected to return cash to shareholders in connection with a winding up of the Company or similar transaction.

 

The Board is pleased to appoint Marathon Capital as financial adviser in conjunction with a potential transaction or transactions. Marathon Capital is a Chicago headquartered industry leading advisory firm with a central focus on sustainable energy.

 

The Board will make further announcements when appropriate.

 

There can be no certainty as to the outcome of the strategic review or any asset sale process, nor whether any potential transaction or transactions arising could be successfully completed or the valuation at which it or they could be completed. In addition, should a transaction arise that would involve the sale of the Company's assets, it is expected that the implementation of such transaction will be conditional upon shareholder approval at a general meeting of the Company.

 

The person responsible for arranging the release of this announcement on behalf of the Company is Martin Darragh. 

 

 

For further information, please contact:

 

Ecofin Advisors, LLC (Investment Manager)

Edward Russell

Eileen Fargis

Jason Benson

Michael Hart

 

 

+1 913 981 1020

Peel Hunt LLP (Joint Corporate Broker)

Liz Yong

Luke Simpson

Huw Jeremy

 

 

+44 20 7418 8900

Stifel (Joint Corporate Broker)

Edward Gibson-Watt

Rajpal Padam

Madison Kominski

 

 

+44 20 7710 7600

Marathon Capital (Financial Adviser)

Ammad Faisal

Gaurav Khanna

Chris Shaw

+1 646 823 1650

 

+44 7770 496 261

Apex Listed Companies Services (UK) Limited (Company Secretary)

Martin Darragh

Maria Matheou

+44 20 3327 9720

FTI Consulting (Financial PR)

Matthew O'Keeffe

Mitch Barltrop

Vee Montebello

 

+44 7976 075 797

 

Further information on the Company can be found on its website at https://uk.ecofininvest.com/funds/us-renewables-infrastructure-trust-plc/.

 

The Company's LEI is 2138004JUQUL9VKQWD21.

 

Marathon Capital Ltd is authorised and regulated by the Financial Conduct Authority and Marathon Capital Markets, LLC is a broker-dealer registered with the U.S. Securities and Exchange Commission and regulated by the Financial Industry Regulatory Authority Inc.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBIGDCGXGDGXR
Date   Source Headline
31st Jan 202312:41 pmRNSReplacement - Dividend Declaration
31st Jan 202312:11 pmRNSDividend Declaration
31st Jan 20237:00 amRNSNet Asset Value(s)
27th Jan 20234:00 pmRNSQuotedData's Weekly News & Interview
26th Jan 202311:30 amRNSUpdate research from QuotedData
19th Jan 20234:12 pmRNSHolding(s) in Company
17th Jan 20237:00 amRNSName Change of Administrator and Company Secretary
14th Dec 202211:13 amRNSDirector/PDMR Shareholding
13th Dec 20223:59 pmRNSDirector/PDMR Shareholding
15th Nov 202211:10 amRNSExchange rate for interim dividend
2nd Nov 20227:00 amRNSPurchase of Management Fee Shares
31st Oct 20227:00 amRNSNet Asset Value(s)
31st Oct 20227:00 amRNSDividend Declaration
31st Oct 20227:00 amRNSQuarterly Factsheet as at 30 September 2022
24th Oct 20227:00 amRNSAppointment of Managing Director and Group Lead
16th Sep 20227:00 amRNSHalf-year Report
14th Sep 20225:16 pmRNSDirector/PDMR Shareholding
14th Sep 202212:36 pmRNSDirector/PDMR Shareholding
17th Aug 202210:04 amRNSExchange rate for interim dividend
1st Aug 20227:00 amRNSTotal Voting Rights
28th Jul 20227:00 amRNSNet Asset Value(s)
28th Jul 20227:00 amRNSDividend Declaration
28th Jul 20227:00 amRNSQuarterly Factsheet as at 30 June 2022
28th Jul 20227:00 amRNSIssue of Management Fee Shares
19th Jul 20227:00 amRNSInvestment Management Update
15th Jul 20224:18 pmRNSHolding(s) in Company
12th Jul 20224:46 pmRNSDirector/PDMR Shareholding
12th Jul 20224:45 pmRNSDirector/PDMR Shareholding
22nd Jun 20224:57 pmRNSResult of AGM
22nd Jun 20227:00 amRNSAGM Update
1st Jun 20227:00 amRNSTotal Voting Rights
30th May 20222:11 pmRNSExchange rate for the interim dividend
24th May 20223:48 pmRNSDirector/PDMR Shareholding
20th May 20227:00 amRNSResults of Placing and REX Retail Offer
10th May 20227:01 amRNSREX Retail Offer
10th May 20227:00 amRNSLaunch of Placing to fund near-term pipeline
3rd May 20223:15 pmRNSTotal Voting Rights
29th Apr 202212:38 pmRNSDirector Declaration
28th Apr 20227:05 amRNSIssue of Equity
28th Apr 20227:02 amRNSDividend Declaration
28th Apr 20227:00 amRNSNet Asset Value(s)
19th Apr 20227:00 amRNSAnnual Financial Report
13th Apr 202212:17 pmRNSDirector/PDMR Shareholding
13th Apr 202211:41 amRNSDirector/PDMR Shareholding
4th Apr 20227:00 amRNSAppointment of Joint Broker
25th Mar 202212:41 pmRNSResearch from QuotedData
11th Mar 20227:00 amRNSNet Asset Value at 31 December 2021
1st Mar 202212:54 pmRNSExchange rate for Interim dividend
31st Jan 20222:38 pmRNSPurchase of Management Fee Shares
27th Jan 20227:00 amRNSInterim Dividend Declaration and Quarterly NAV

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.